ACADIA Pharmaceuticals Inc. (ACAD) Revenue Growth
ACADIA Pharmaceuticals Inc. (ACAD) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | 620.68% |
| 2018-12-31 | 79.19% |
| 2019-12-31 | 51.50% |
| 2020-12-31 | 30.28% |
| 2021-12-31 | 9.60% |
| 2022-12-31 | 6.83% |
| 2023-12-31 | 40.45% |
| 2024-12-31 | 31.85% |
| 2025-12-31 | 11.87% |
How ACAD compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| BMRN | BioMarin Pharmaceutical Inc. | 12.87% |
| INNV | InnovAge Holding Corp. | 11.76% |
| EOLS | Evolus Inc. | 11.61% |
| EW | Edwards Lifesciences Corporation | 11.55% |
| NEO | NeoGenomics Inc. | 10.11% |
These are five companies in the same sector as ACAD with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get ACADIA Pharmaceuticals Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("ACAD", 2025, "")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | ACAD | $19.71 | +2.39% | 1.77M |
| 3 | ||||
| 4 | ||||
| 5 |